119 results
424B5
MRSN
Mersana Therapeutics Inc
9 May 24
Prospectus supplement for primary offering
5:06pm
Stock Incentive Plan, 2022 Inducement Stock Incentive Plan, and 2017 Employee Stock Purchase Plan, respectively, as well as any automatic increases … in the number of shares of common stock reserved under our 2017 Stock Incentive Plan and 2017 Employee Stock Purchase Plan.
Unless otherwise indicated, all
8-K
EX-99.1
MRSN
Mersana Therapeutics Inc
9 May 24
Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results
7:10am
employee compensation following the restructuring announced by the company in July 2023.
General and administrative (G&A) expenses for the first quarter … and professional services fees and reduced employee compensation expense following the aforementioned restructuring.
Net loss for the first quarter of 2024
8-K
EX-1.1
MRSN
Mersana Therapeutics Inc
28 Feb 24
Entry into a Material Definitive Agreement
4:08pm
with ERISA. (i) Each employee benefit plan, within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA … director or officer of the Company or its subsidiary nor, to the knowledge of the Company, any agent, employee, affiliate or other person associated
424B5
2de s3mk911de
28 Feb 24
Prospectus supplement for primary offering
4:07pm
POS AM
rol6kj qhb
28 Feb 24
Prospectus update (post-effective amendment)
4:05pm
POSASR
upwr1p9c90pr8o4
28 Feb 24
Automatic shelf registration (post-effective amendment)
8:43am
8-K
EX-99.1
7vgw2 ljlsqlfau8
28 Feb 24
Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results
7:07am
S-8
8oneegwcz
12 Jan 24
Registration of securities for employees
4:42pm
S-8
EX-5.1
gqe50m72gju
12 Jan 24
Registration of securities for employees
4:42pm
S-8
EX-23.2
5mpguqdy7bxpzsmal
12 Jan 24
Registration of securities for employees
4:42pm
S-8
3q8srx
12 Jan 24
Registration of securities for employees
4:42pm